This project will determine what components of the immune response are involved in the in vivo human tumor host relationship. The immune cell infiltrate in and around lymphoid neoplasms will be studied in frozen tissue sections. Different types of T cells, B cells, and accessory cells will be identified with various hybridoma monoclonal antibodies and detection methods employing antibodies, biotin, avidin, and horseradish peroxidase. Methodology for enumerating cells in sections will allow accurate comparison of cell types in multiple neoplasms of similar type as well as with those in normal and hyperplastic lymphoid tissues. The type of immune infiltrate will be correlated with tumor phenotype and expression of HLA antigens. The type and amount of infiltrate will also be compared with anatomic site of involvement and various clinical parameters in an attempt to predict certain clinical characteristics. The categorizing of immune infiltrates may prove useful in experimental treatment strategies employing monoclonal antibodies coupled to particular effector cells. For example, an initial study of patients with low grade B cell lymphoma treated with monoclonal anti-idiotype therapy indicates that complete responders have significantly more T cells, TAC+ cells, and Leu 7+ cells in pretreatment tissues when compared to nonresponders. A long-range goal is to assess the stability of tumor phenotype and immune infiltrate at similar and differing sites as a function of time and treatment. New double-label methods and fixation and processing techniques will be developed and refined to allow extremely precise localization of cellular antigens. Such an in vivo evaluation of tumor host relationship should provide valuable insights in tumor biology. (IP)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA033119-03
Application #
3171080
Study Section
Experimental Immunology Study Section (EI)
Project Start
1984-01-01
Project End
1987-12-31
Budget Start
1986-01-01
Budget End
1987-12-31
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Matolcsy, A; Warnke, R A; Knowles, D M (1997) Somatic mutations of the translocated bcl-2 gene are associated with morphologic transformation of follicular lymphoma to diffuse large-cell lymphoma. Ann Oncol 8 Suppl 2:119-22
Matolcsy, A; Casali, P; Warnke, R A et al. (1996) Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene. Blood 88:3937-44
Gelb, A B; van de Rijn, M; Warnke, R A et al. (1996) Pregnancy-associated lymphomas. A clinicopathologic study. Cancer 78:304-10
Soslow, R A; Davis, R E; Warnke, R A et al. (1996) True histiocytic lymphoma following therapy for lymphoblastic neoplasms. Blood 87:5207-12
Hoppe, R T; Medeiros, L J; Warnke, R A et al. (1995) CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides. J Am Acad Dermatol 32:448-53
LeBrun, D P; Ngan, B Y; Weiss, L M et al. (1994) The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma. Blood 83:223-30
Gelb, A B; van de Rijn, M; Regula Jr, D P et al. (1994) Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia. Hum Pathol 25:953-60
Parsonnet, J; Hansen, S; Rodriguez, L et al. (1994) Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330:1267-71
Gelb, A B; Dorfman, R F; Warnke, R A (1993) Coexistence of nodular lymphocyte predominance Hodgkin's disease and Hodgkin's disease of the usual type. Am J Surg Pathol 17:364-74
Gelb, A B; Smoller, B R; Warnke, R A et al. (1993) Lymphocytes infiltrating primary cutaneous neoplasms selectively express the cutaneous lymphocyte-associated antigen (CLA). Am J Pathol 142:1556-64

Showing the most recent 10 out of 31 publications